$FSLR

FSLR Maintained by JP Morgan -- Price Target Lowered to $252

JP Morgan maintained an overweight rating on First Solar (FSLR) but lowered its price target from $256 to $252. GuruFocus values FSLR at $250.06, suggesting a 31.3% undervaluation. Insiders sold $2.2M in shares over 3 months. FSLR has a GF Score of 90/100, indicating strong financial health and growth potential.

Original reporting
Published Oct 19, 2026, 8:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$FSLR
Bearish
medium confidence
Mentioned
$FSLR
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$FSLRBearishMed
01

Why it matters

The price‑target reduction reflects perceived short‑term challenges, potentially prompting a modest pullback in the stock.

02

Market read

Analyst target adjustment provides a new data point for traders evaluating First Solar and the broader solar sector.

03

What to watch

Insider selling activity and broader renewable‑energy policy changes could further influence the stock.

Relevance 7/10Novelty 6/10Timing: today

Background

First Solar is a leading thin‑film solar module manufacturer with a market cap of ~$18 bn. The analyst note highlights valuation concerns amid sector dynamics.

Company-level read

Ticker impact

$FSLRBearishMedium confidence
Context

JP Morgan maintained overweight on First Solar but lowered its price target from $256 to $252.

Expected impact

likely slight price decline as investors price in the lower target.

Evidence & confidence

Analyst price‑target reductions typically lead to short‑term selling pressure, especially when the rating remains unchanged.

Market effects

The downgrade may weigh on other solar and renewable‑energy stocks as investors reassess sector valuations.

Limited to U.S. listed renewable‑energy equities.

Minimal; the news is company‑specific.

Counterpoint

Some investors may view the unchanged overweight rating as a sign of confidence despite the target cut.

Key entities

  • First Solar Inc.

    US‑listed solar module manufacturer (ticker FSLR).

  • JP Morgan

    Maintained overweight rating while lowering price target.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$FSLRHigh

Why First Solar (FSLR) Stock Is Up Today

First Solar (FSLR) stock rose 1.8% after Truist Securities upgraded it to Buy with a $229 price target, citing improved pricing and demand forecasts. Shares later cooled to $180.10, up 1.3%. The upgrade follows a 32% YTD decline, with the analyst noting strong domestic demand and anti-stockpiling restrictions benefiting the company.

$FSLRHigh

Truist upgrades First Solar stock rating on stronger pricing outlook

Truist upgraded First Solar (FSLR) to Buy, raising its price target to $270 from $229. The upgrade is based on stronger pricing outlook and valuation reset, with a 17% increase in 2029 U.S. module ASP estimates. Truist forecasts strong U.S. solar installations and cites regulatory support. Other analysts have also upgraded FSLR, citing undervaluation and potential earnings drivers.

$FSLRHigh

Why is First Solar stock up over 2% today?

First Solar (FSLR) stock rose 2.4% in pre-market trading after Truist Securities upgraded it to 'Buy' and raised its price target to $270, citing favorable pricing and regulatory conditions. The stock is still below its 52-week high of $320.95. Analysts have largely positive ratings, with 26 Buys, 9 Holds, and 1 Sell. The broader market is mixed ahead of bank earnings season.